Clinical Trial

PCDD Generation 1 Oral Liquid Acetaminophen Delivery Evaluation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective randomized pilot study evaluates the feasibility, acceptability, and preliminary efficacy of the Patient-Controlled Dispenser and Deactivator (PCDD) Generation 1 system for patient-controlled oral liquid acetaminophen administration in postoperative total shoulder replacement inpatients compared with standard nurse-administered oral acetaminophen delivery.
Trial Details
NCT Number NCT07765238
Lead Sponsor Yale University
Conditions Pain Management, Postoperative Pain
Enrollment 60 participants
Start Date 2026-08
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-14